News | Kneu Health

Skip to main content

How it works Providers and Payers Parkinson’s disease Dementia

Company

About
How it works
Our science
News

Services

Parkinsons
Dementia
Providers and Payers

Legal

Cookie Policy
Privacy Policy
Terms of Use

Contact & Support

Request a demo
General inquiries
Patients Support
Frequently Asked Questions

Follow us on Social media

Kneu Health is a MHRA registered and FDA cleared medical device.

Kneu Health Ltd is registered in England and Wales with company number 14492037 and its registered office is at First Floor, 100 Victoria Embankment, London, EC4Y 0DH, United Kingdom. It is registered under the Data Protection Act No. ZB541090. U.S. Patent No. 12,569,185. © 2026 Kneu Health Ltd. All rights reserved.

FilterCompany news Partnerships Impact Platform updates Perspectives

Impact

Kneu Health Revolutionizes Parkinson's Care: A Health Innovation East Impact Story

February 20, 2025

Company news

Kneu Health Secures $2 Million Investment from Cedars-Sinai and Oxford Science Enterprises to Revolutionize Neurology Care

January 29, 2025

Impact | Company news

Kneu Health Celebrates HSJ Awards Win for Digitising Patient Care

November 22, 2024

Company news | Platform updates

Kneu Health Now Available on G-Cloud 14: Making Parkinson's and Dementia Care Accessible For All

October 31, 2024

Company news | Impact

Kneu Health, ESNEFT & Health Innovation East Shortlisted for the 2024 HSJ Awards, Setting a New Standard for Healthcare Excellence

August 12, 2024

Company news | Partnerships

Kneu Health Joins Cedars-Sinai Accelerator to Revolutionize Parkinson's Disease and Dementia in the US

August 2, 2024

Impact

Pioneering Parkinson's Care: The First NHS Outcomes using the Kneu Health Platform

July 23, 2024

Impact | Platform updates

Pioneer Intervention Program: Our Patient-Led Design Initiative

June 17, 2024

Company news | Impact

NHS Partnership Announcement: Kneu Health & Leeds Teaching Hospital Trust

May 21, 2024

Showing 19–27 of 34 results